Metoprolol-Egis

Metoprolol, the active ingredient in Metoprolol‑Egis, is a beta blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, chest pain from angina, heart failure, and to improve survival after a myocardial infarction in adult patients.

GNH USA supplies Metoprolol‑Egis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Metoprolol is a selective β1‑adrenergic blocker used in several cardiovascular conditions.

- Hypertension: lowers systemic blood pressure by reducing cardiac output and inhibiting renin release. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Heart failure: improves ventricular function and reduces mortality in chronic heart failure patients. - Post‑myocardial infarction: lowers the risk of recurrent cardiac events and improves long‑term survival.

Metoprolol may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea or abdominal discomfort. - Headache: mild to moderate pain in the head.

Serious or Rare Side Effects: - Severe bradycardia: dangerously low heart rate requiring medical attention. - Heart block: impaired electrical conduction through the heart. - Bronchospasm: narrowing of airways, particularly in asthmatic patients. - Hypotension: marked drop in blood pressure causing faintness. - Allergic reactions: rash, itching, or swelling of the face and throat. - Depression: mood changes or worsening depressive symptoms.

When prescribing Metoprolol, clinicians should observe several precautionary measures to ensure safety.

- Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess heart rate: ensure rate remains within therapeutic range. - Use caution in asthma/COPD: β1 selectivity may not fully prevent bronchoconstriction. - Adjust in renal/hepatic impairment: dose may need modification based on organ function. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Metoprolol can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Verapamil or diltiazem: combined use can cause severe bradycardia or heart block. - Clonidine withdrawal: abrupt cessation of clonidine while on Metoprolol may precipitate hypertension. - Other AV‑node blockers (e.g., digoxin): increase risk of conduction abnormalities.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect. - Diuretics: can enhance hypotensive response. - Antidepressants (e.g., SSRIs): may affect heart rate control. - Antidiabetic agents: Metoprolol may mask hypoglycemia symptoms. - Calcium channel blockers (non‑diltiazem): may require dose adjustment.